The Lecture Hall

Let's Learn About CRC
Introduction
Metastatic colorectal cancer: Dr. Kasi
Treatment updates 2020: Patient perspective with Dr. Manju George
Biomarkers and CRC: An introduction
Treating metastatic CRC with radiotherapy: Dr. Sanford
The role of precision medicine in the treatment of CRC: Dr. Bekaii-Saab
CtDNA Testing For CRC
New treatment strategies for MSS CRC: Dr. Parikh
Circulating tumor DNA: a new frontier in colorectal cancer: Dr. Cohen
Minimal residual disease in colorectal cancer — Update after ASCO-GI 22: Dr. Kopetz
CtDNA screening tests and the CIRCULATE-US trial: Dr. Lieu
CtDNA testing for patients undergoing liver resection: Dr. Newhook
CtDNA DYNAMIC II clinical trial: Dr. Tie
Immunotherapy
What is immunotherapy?
CRC and immunotherapy: Dr. Keenan
Antibody drug conjugates in CRC: Dr. Raghav
Immunotherapy in MSS Colorectal Cancer: Dr. Fakih
The TIL trial for metastatic CRC: Drs. Lou and Starr
CAMILLA trial — Cabo + Durva for metastatic refractory MSS CRC: Dr. Saeed
Defining early-onset CRC and improving outcomes for MSI-H rectal cancer: Dr. Cercek
Clinical Trials
Clinical trials resources
Clinical trials demystified, part 1: Adrian Terek
Clinical trials demystified, part 2: Dr. Kurzrock
How to search clinicaltrials.gov
CRC trials in Canada: Dr. Loree
Clinical trials and second opinions at MD Anderson
Lessons from precision medicine and early phase trials: Dr. Kurzrock
PACES trial: Dr. Zell
ERASur trial: Local treatment options for limited stage IV CRC
BREAKWATER trial: Dr. Kopetz
Clinical trials and advanced cancer care at NIH: Dr. Klemen
Phase I trials: Dr. Sharma
TIL trial: Dr. Klemen
BRAF Talks
About BRAF
BRAF V600E research update: Dr. Corcoran (2020)
Overview of BRAF treatment options: Dr. Kopetz (2020)
Targeted therapies and immunotherapy: Dr. Morris (2020)
Tackling targeted therapy refractory BRAF V600E mCRC: Dr. Kopetz (2021)
HERKULES-3 trial for BRAF and RAS: Dr. Lee (2021)
BRAF-mutated CRC updates: Dr. Corcoran (2022)
RAS Talks
KRAS therapies for CRC: Dr. Kopetz
Targeting RAS mutations in CRC: Dr. Lenz
HER2/ERBB2 Talks
HER2 as an emerging target for metastatic CRC patients: Dr. Strickler
All Things Liver
Intro: Liver mets
Advanced surgical treatments for CRC liver mets: Dr. Hernandez-Alejandro
Transplant patients are in the house!
SIRT Y-90 for liver mets
Hepatic Artery Infusion (HAI) chemotherapy for CRC liver mets: Dr. Gholami
Modern-day management of liver metastases: Dr. Soares
Why liver transplant for mCRC is taking off: Dr. Hernandez-Alejandro
Paths to long-term survival with CRC liver mets: Dr. Hernandez-Alejandro
How ablation can be a cancer terminator for liver and lung mets: Dr. Arellano
HAI pump trial: Drs. Cercek, D’Angelica, Lidsky and Maithel
Interview with an icon: Dr. Kemeny on HAI pumps
LUNG METASTASES
Lung surgery for colorectal cancer metastasis: Dr. Atay
Peritoneal Metastases
Peritoneal metastases: Drs. Klempner, Sgarbura, Gongura, & Hübner
Krukenberg tumors and mets to female reproductive organs: Drs. Xie & Sood
The Conference Center: Research Roundups
What are poster walks?
ASCO 2021 Poster Walks
Colorectal cancer conference roundup 2022: Dr. Krishnamurthi & Dr. Eng
CRC updates from GI23: Drs. Eng, Saeed, Smith & Sanford
CRC updates from ASCO 23: Drs. Smith, Krishnamurthi & Sanford
Rectal Cancer
Demystifying radiotherapy in rectal cancer: Dr. Sanford
Radiation in rectal cancer: Dr. VanderWalde
Watch and wait for localized rectal cancer: Dr. Chakrabarti
Update from ASCO 2021
Sexual health after treatment: Dr. Bober
The evolving role of proton therapy for rectal cancer patients: Dr. Jethwa
Non-operative management of rectal cancer: Dr. Kim
Non-operative management of rectal cancer: Dr. Smith
Updates in the treatment of locally advanced rectal cancer: Dr. Ciombor
Defining early-onset CRC and improving outcomes for MSI-H rectal cancer: Dr. Cercek
PROSPECT trial: Dr. Schrag
Risk of local regrowth after watch and wait in rectal cancer: Dr. Perez
Anal Cancer
Anal cancer developments in 2022: Dr. Eng
Practical Considerations
Prognostication or prophecy: Dr. Briscoe
End-of-life doulas: Amy Bishop
Second opinions: Dr. Lidsky
PTA Resource Fair: Programs & services for kids whose parent has or had cancer
Resource Fair: Mental wellness
Questions? Feedback?
Contact us
Donate
Previous Topic
Next Topic

Clinical trials demystified, part 1: Adrian Terek

The Lecture Hall Clinical trials demystified, part 1: Adrian Terek

COLONTOWN Deputy Mayor Julie Saliba and Scientific Director Dr. Manju George host this information-packed chat with Adrian Terek, COLONTOWN’s Trial Curator and the founder of an innovative trial resource, LifeTrials.

Adrian offers insights into how to look at potential trial options, understand trial objectives and how they relate to your own objectives as a patient, and shares his deep knowledge about the cancer trials ecosystem.

Previous Topic
Back to Learning Center
Next Topic